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Studies have been conducted on isolated segments of the
left circumflex coronary artery of the dog to gain infor-
mation on the mechanism or mechanisms of vasospasm.
Coronary arteries contain both postjunctional alpha.-
and beta.-adrenoceptors, and both are accessible to nor-
epinephrine released from the sympathetic nerves. How-
ever, owing to the dominance of the beta.-adrenoceptors,
sympathetic stimulation causes relaxation of the vascular
smooth muscle. In the primary branches of the circum-
flex artery, only beta.-adrenoceptors are present. In pa-
tients with spasm of the coronary arteries, blockade of
the beta.-adrenoceptors may aggravate the spasm by
permitting the unopposed constrictor action of the sym-
pathetic nerves on the alpha.-adrenoceptors on these
vessels.
The blood platelets contain substances, including 5-
hydroxytryptamine (serotonin) and thromboxane A2,
Mechanisms responsible for coronary spasm. The
demonstration by Furchgott (1) that acetylcholine can cause
an endothelium-dependent relaxation of vascular smooth
muscle has focused attention on the importance of the vas-
cular endothelium in the normal control of the blood vessels
and on the relation ofendothelial damage to spasm of human
cerebral, coronary and digital arteries. The present report
summarizes studies conducted on the main coronary arteries
of the dog that have relevance to the causation of variant
angina (2). The term variant angina was coined by Prinz-
metal et a1. (3) to describe anginal pain that, unlike classic
angina of effort, develops at rest, often in the early morning
hours. Because the work of the heart is not increased, the
pain must be due to a metabolic deficit caused by a reduction
in coronary blood flow. Prinzmetal et a1. suggested that the
angina was caused by a spasm of a major coronary artery
because it was relieved quickly by administration of nitro-
glycerin. Since then, many additional observations have
confirmed that the angina is caused by spasm of the main
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which can cause constriction of vascular smooth muscle.
These substances are released whenever platelets aggre-
gate. The normal endothelium, by forming and releasing
prostacyclin, inhibits platelet aggregation. In addition,
in response to platelet products, the normal endothelium
forms one or more inhibitory substances that cause re-
laxation of the underlying smooth muscle. Also, if any
thrombin is formed, this also causes an endothelium-
mediated relaxation of the artery. Patients with coronary
artery spasm usually have morphologic changes in the
artery at the site of the spasm. Thus, platelets can ag-
gregate at the site and the resultant release of serotonin
and thromboxane A2, acting directly on the smooth mus-
cle, causes constriction of the artery. Hypoxia of the
myocardium follows and this augments the constriction.
(J Am Coil CardioI1986;8:50A-54A)
coronary artery or arteries. Coronary angiography reveals
that many patients have varying degrees of vascular ob-
struction in one main artery, but in a few patients no ab-
normality is detected (4-6). Even in those patients with
little evidence from the angiogram of any vascular abnor-
mality, the intravenous administration of ergonovine ma-
leate, a naturally occurring ergot alkaloid, can cause a pro-
longed isolated contraction of a main coronary artery, thus
revealing a region especially susceptible to vasoconstriction
(6,7). Thus, although the clinical manifestations are well
defined, the mechanism or mechanisms responsible for the
episodes of spasm are not.
Various theories have been advanced including:
1) Asymmetric stimulation of the sympathetic nerves to the
heart, leading to alpha-adrenergically mediated constriction
of the coronary artery (8,9). However, more recent studies
(0) have shown that activation of the sympathetic nerves
causes dilation of the main coronary arteries due to the
predominance of betal- over alphal-adrenoceptors. 2) A de-
crease in the numbers of alpha-adrenoceptors or the sym-
pathetic nerve terminals or in their affinity (11). These re-
ceptors, if activated, can reduce the output of norepinephrine
from the nerve endings. However, if they no longer provide
this negative feedback on neurotransmitter release, more
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norepinephrine will be released, and this should cause a fur-
ther dilation rather than constriction of the major coronary
arteries. 3) Incorporation of cholesterol into the membranes
of the smooth muscle cells of the arteries, thus facilitating
their constriction when the sympathetic nerves are activated
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Figure 4. Tension recording ofcanine coronary arteries with intact
endothelium, contracted with prostaglandin F2a (PGF2a). Adeno-
sine diphosphate (ADP) caused marked relaxation, which was
maximal by 10-4 M (top). In some rings there was a partial
recovery of tension in the presence of ADP; when platelets
(9.8 x 107/ml) were added at this time, they did not cause relax-
ation, whereas in the paired ring without ADP, the relaxation to
platelets was typical (bottom). Acetylcholine (ACh), even in the
presence of ADP and platelets, was still able to induce relaxation.
(Reprinted with permission from Houston DS, et al. [18].)
(12), 4) Platelet aggregation with release of vasoconstrictor
agents (13-15). These various ideas illustrate the necessity
of understanding the function of the autonomic nerves to
the coronary vessels, the types of receptors on their smooth
muscle cells and autonomic nerve endings, and the reaction
of the smooth muscle and the endothelium to substances
formed in the heart or released from the blood elements, or
both.
The nature of the receptors at the neuroefTector junc-
tion of the main coronary arteries. Adrenergic receptors
are classified as alphal' alphaz, beta] and betaz. In the canine
left circumflex coronary artery, beta.-adrenoceptors pre-
dominate over alphal-adrenoceptors and in the first branches
Figure 3. When coronary artery rings are exposed to aggregating
platelets, they relax if the endothelium is intact (top) but contract
if it is removed (bottom). PGF2Q = prostaglandin F2a- (Reprinted
with permission from Cohen RA. Inhibitory role of the endothe-
lium in the response of isolated coronary arteries to platelets.
Science 1983;221:273-4.
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Figure 1. Adrenoceptors in canine coronary artery neuroeffector
junction. In large vessels, such as the left circumflex artery, both
postjunctional alpha]- and betal-adrenoceptors (al and {31) are pres-
ent, but the latter predominate functionally. When the adrenocep-
tors are activated, the former cause contraction and the latter cause
relaxation of smooth muscle. In branch arteries, only beta\-adren-
oceptors are present. As in all blood vessels that have been ex-
amined, alpha2-adrenoceptors (a2) are present on the sympathetic
nerve terminals. When activated, these adrenoceptors reduce the
output of the neurotransmitter. NE = norepinephrine. (Reprinted
with permission from Vanhoutte PM. Autonomic nerves, aggre-
gating platelets and contraction of coronary arterial smooth muscle.
In: Abel FL, Newman WH, eds. Functional Aspects ofthe Normal,
Hypertrophied and Failing Heart. Boston: Martinus Nijhoff,
1984: 125-48.)
Figure 2. Interaction of cholinergic with adrenergic nerves at the
coronary neuroeffector junction. Acetylcholine (ACh), released
when cholinergic nerves are activated, acts on muscarinic receptors
(M) on the sympathetic nerves to reduce the output of norepi-
nephrine (NE). Because less norepinephrine is then available to
activate the beta-adrenoceptors ({3), the degree of smooth muscle
relaxation is reduced. a2 = alpharadrenoceptors. (Reprinted from
Shepherd JT. The heart as a sensory organ. J Am Coll Cardiol
1985;5:83-7B.)
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Figure 7. Effect of anoxia on endothelium-mediated relaxation
of an isolated femoral artery of the dog. Left, In a ring of the
artery in the presence of 95% oxygen and contracted with nor-
epinephrine, acetylcholine causes a dose-dependent relaxation. This
response is mediated by endothelial cells because no relaxation
occurs in their absence. In the presence of endothelial cells, anoxia
(95% nitrogen) also prevents the relaxation attributable to acetyl-
choline. Right, Results of similar studies show that anoxia presents
the endothelium-mediated relaxation caused by thrombin. • =
Endothelium intact; 0 = endothelium intact, anoxic; 0 = en-
dothelium removed. (Reprinted with permission from Shepherd
IT and Vanhoutte PM [2).)
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Figure 8. Contraction of a ring from a main coronary artery with
5-hydroxytryptamine and the effect of hypoxia. When the ring is
made hypoxic, contraction is considerably augmented. (Reprinted
with permission from Van Nueten 1M and Vanhoutte PM. Sero-
tonin and vascular function. Clin Anesth 1984;2:363.)
nerves causes relaxation, due to the predominant action of
the released norepinephrine on the beta\-adrenoceptors and
not, as previously thought, constriction of these vessels (Fig.
1). This explains the clinical observation that beta-adren-
oceptor blocking agents may augment coronary vasospasm
(16). Alphaz-adrenoceptors and muscarinic receptors are
present on the sympathetic nerve endings of the coronary
arteries. Their activation by norepinephrine and acetylcho-
line, respectively, reduces the output of the sympathetic
neurotransmitter which could lessen the dilation of these
vessels. The vagal nerves to the coronary vessels may act
primarily on these muscarinic receptors (Fig. 2). It has been
shown that muscarinic agonists can precipitate coronary
vasospasm in humans (17).
Aggregating
platelets
Endothelial
cells
Figure 6. When the endothelium is damaged, platelets aggregate
because of the absence of prostacyclin. Substances released from
the platelets, including 5-hydroxytryptarnine (5-HT), thromboxane
Az (TBAz) and adenosine diphosphate (ADP), cause contraction
of the smooth muscle. Formation of thrombin may enhance the
contraction. (Reprinted with permission from Shepherd JT and
Vanhoutte PM [2].)
of this vessel there are only beta\-adrenoceptors. When the
beta\-adrenoceptors are stimulated, the cell membrane be-
comes hyperpolarized, the production of cyclic adenosine
monophosphate (AMP) is accelerated, the concentration of
Ca2 + in the cytoplasm of the smooth muscle cells is reduced
and the muscle relaxes. Thus, stimulation of the sympathetic
Figure S. Importance of endothelium in generating inhibitory
signals to smooth muscle when exposed to elements involved in
blood coagulation. Prostacyclin (PGIz), formed in the endothelial
cells, inhibits platelet aggregation. If some platelets aggregate and
release 5-hydroxytryptamine (5-HT), thromboxane Az (TBAz) and
adenosine diphosphate (ADP), the endothelium forms as yet un-
known substances that relax the smooth muscle. In addition, the
enzyme monoamine oxidase (MAO) in the endothelial cells degrades
5-hydroxytryptamine. Furthermore, any thrombin that is formed
also leads to relaxation of the smooth muscle by formation of an
inhibitory substance in the endothelium. (Reprinted with permis-
sion from Shepherd IT and Vanhoutte PM [2).)
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Role of the endothelium. The normal endothelium and
the vascular smooth muscle cells produce prostacyclin, an
endogenous vasodilator, which also inhibits platelet aggre-
gation. The platelets contain thromboxane Az which facil-
itates platelet aggregation and causes constriction of vas-
cular smooth muscle. Whenever platelets aggregate, other
vasoactive substances, in addition to thromboxane Az, are
liberated. These include 5-hydroxytryptamine (serotonin)
and adenosine diphosphate.
If segments of the circumflex coronary arteries of the
dog are made to contract with prostaglandin Fzw they relax
when exposed to aggregating platelets, provided the en-
dothelium is intact. If the endothelium is removed, the seg-
ment undergoes a further contraction (Fig. 3). The relaxation
is due mainly to the action of the released adenosine di-
phosphate on the endothelial cells (Fig. 4), and partly to
the action of 5-hydroxytryptamine (Fig. 5). As a conse-
quence of the exposure to these substances, the endothelial
cells liberate one or more vasoactive substances that cause
relaxation of the underlying smooth muscle (2,18). The
presence of the enzyme monoamine oxidase in the endo-
thelium also permits 5-hydroxytryptamine to be degraded
(Fig. 5).
In miniature swine with selective atherosclerotic lesions
in their coronary arteries and normal coronary angiograms,
histamine and 5-hydroxytryptamine caused spasm of the
artery only at the sites where the endothelium was denuded
(19), In dogs, there is a close correlation between early
atherosclerotic changes and enhanced segmental vasocon-
striction to ergonovine and 5-hydroxytryptamine (20). Rings
taken from human epicardial arteries that had atherosclerotic
lesions had an enhanced contractile response to histamine
(21). Patients who develop coronary artery spasm usually
have atherosclerotic lesions at the site in the artery where
spasm occurs (22). Thus, when the vascular endothelium is
damaged there is diminished production of prostacyclin; this
favors platelet aggregation and the release of adenosine di-
phosphate, 5-hydroxytryptamine and thromboxane Az. In
the absence of the protective role of the endothelium, con-
striction of the underlying smooth muscle ensues (Fig. 3
and 6). In the presence of normal endothelium, thrombin
also causes an endothelium-dependent relaxation; in the
presence of a damaged endothelium, the vasodilatory re-
sponse to thrombin is lost (Fig. 5). As a consequence of
the strong constriction of the vascular smooth muscle, the
blood supply to the myocardium is reduced and hypoxia
supervenes. When hypoxia occurs at the site of an athero-
sclerotic lesion, it prevents normal endothelium in the area
from forming any substance that relaxes the underlying smooth
muscle, and it also enhances the constrictor action of 5-
hydroxytryptamine on the smooth muscle (Fig. 7 and 8).
Those who smoke have an additional risk, because smoking
can decrease the integrity of endothelial cells (23).
Conclusions. It seems that coronary vasospasm can be
explained by the loss of the protective role of the endothe-
lium and the resultant failure to produce one or more en-
dothelium-dependent relaxing substances to counteract the
direct vasoconstrictor action of substances released from
platelets or formed by the blood elements. Similar factors
may operate in the causation of spasm of cerebral and digital
vessels (Raynaud's disease). The nature of these relaxing
substances and the way in which the endothelium produces
them offer an exciting challenge for future studies.
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